Total Assets (Quarterly) Chart

View Total Assets (Quarterly) for UTHR.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Assets (Quarterly) Chart
Start Trial

Historical Total Assets (Quarterly) Data

View and export this data back to 1999. Start Trial.
Date Value
June 30, 2026 7.220B
March 31, 2026 6.714B
December 31, 2025 7.969B
September 30, 2025 7.351B
June 30, 2025 7.908B
March 31, 2025 7.744B
December 31, 2024 7.438B
September 30, 2024 7.123B
June 30, 2024 6.723B
March 31, 2024 6.495B
December 31, 2023 7.209B
September 30, 2023 7.024B
June 30, 2023 6.681B
March 31, 2023 6.346B
December 31, 2022 6.086B
September 30, 2022 5.782B
June 30, 2022 5.543B
March 31, 2022 5.360B
December 31, 2021 5.199B
September 30, 2021 5.049B
June 30, 2021 4.845B
March 31, 2021 4.641B
December 31, 2020 4.642B
September 30, 2020 4.411B
June 30, 2020 4.219B
Date Value
March 31, 2020 4.026B
December 31, 2019 3.959B
September 30, 2019 4.000B
June 30, 2019 3.899B
March 31, 2019 3.727B
December 31, 2018 3.454B
September 30, 2018 3.412B
June 30, 2018 3.245B
March 31, 2018 3.020B
December 31, 2017 2.898B
September 30, 2017 2.936B
June 30, 2017 2.692B
March 31, 2017 2.561B
December 31, 2016 2.357B
September 30, 2016 2.269B
June 30, 2016 2.202B
March 31, 2016 2.192B
December 31, 2015 2.219B
September 30, 2015 2.159B
June 30, 2015 1.737B
March 31, 2015 1.895B
December 31, 2014 1.884B
September 30, 2014 2.072B
June 30, 2014 1.953B
March 31, 2014 2.115B

Total Assets Definition

Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.

Read full definition.

Total Assets (Quarterly) Range, Past 5 Years

View Total Assets (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Assets (Quarterly) Benchmarks

View Total Assets (Quarterly) Benchmarks
Start Trial
Liquidia Corp. 521.92M
Insmed, Inc. 2.103B
MannKind Corp. 732.30M
Vertex Pharmaceuticals, Inc. 27.42B
BioMarin Pharmaceutical, Inc. 11.72B

Total Assets (Quarterly) Related Metrics